A systematic review on the role of adjunctive corticosteroids in herpes simplex virus encephalitis: Is timing critical for safety and efficacy?

Ciro Ramos-Estebanez, Karlo J. Lizarraga, Amedeo Merenda

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background: Most herpes simplex virus encephalitis (HSVE) patients become disabled despite antiviral therapy. Adjunctive corticosteroid therapy may improve outcomes. Methods: This was a systematic review of the literature addressing the use of corticosteroids in HSVE. Results: Data suggesting that steroids decrease the immunological response and enhance viral replication originated from non-neural microenvironments. Early steroid administration might be harmful because initial damage in HSVE is mediated by viral replication. Steroid treatment improves outcomes in animal models by inhibiting the subsequent inflammatory response. Clinical observations support a similar benefit in symptomatic HSVE patients. Cerebrospinal fluid inflammatory markers might guide appropriate timing in future clinical practice. Conclusions: Experimental and clinical observations suggest a benefit from adjunctive steroid therapy in HSVE. Nevertheless, current evidence is not yet sufficient to endorse this approach as a standard of practice.

Original languageEnglish
Pages (from-to)133-139
Number of pages7
JournalAntiviral Therapy
Volume19
Issue number2
DOIs
StatePublished - Jan 1 2014

Fingerprint

Herpes Simplex Encephalitis
Simplexvirus
Adrenal Cortex Hormones
Safety
Steroids
Antiviral Agents
Cerebrospinal Fluid
Therapeutics
Animal Models

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

A systematic review on the role of adjunctive corticosteroids in herpes simplex virus encephalitis : Is timing critical for safety and efficacy? / Ramos-Estebanez, Ciro; Lizarraga, Karlo J.; Merenda, Amedeo.

In: Antiviral Therapy, Vol. 19, No. 2, 01.01.2014, p. 133-139.

Research output: Contribution to journalArticle

@article{aa42267aee9d44e7abac0e14f6a0bc29,
title = "A systematic review on the role of adjunctive corticosteroids in herpes simplex virus encephalitis: Is timing critical for safety and efficacy?",
abstract = "Background: Most herpes simplex virus encephalitis (HSVE) patients become disabled despite antiviral therapy. Adjunctive corticosteroid therapy may improve outcomes. Methods: This was a systematic review of the literature addressing the use of corticosteroids in HSVE. Results: Data suggesting that steroids decrease the immunological response and enhance viral replication originated from non-neural microenvironments. Early steroid administration might be harmful because initial damage in HSVE is mediated by viral replication. Steroid treatment improves outcomes in animal models by inhibiting the subsequent inflammatory response. Clinical observations support a similar benefit in symptomatic HSVE patients. Cerebrospinal fluid inflammatory markers might guide appropriate timing in future clinical practice. Conclusions: Experimental and clinical observations suggest a benefit from adjunctive steroid therapy in HSVE. Nevertheless, current evidence is not yet sufficient to endorse this approach as a standard of practice.",
author = "Ciro Ramos-Estebanez and Lizarraga, {Karlo J.} and Amedeo Merenda",
year = "2014",
month = "1",
day = "1",
doi = "10.3851/IMP2683",
language = "English",
volume = "19",
pages = "133--139",
journal = "Antiviral Therapy",
issn = "1359-6535",
publisher = "International Medical Press Ltd",
number = "2",

}

TY - JOUR

T1 - A systematic review on the role of adjunctive corticosteroids in herpes simplex virus encephalitis

T2 - Is timing critical for safety and efficacy?

AU - Ramos-Estebanez, Ciro

AU - Lizarraga, Karlo J.

AU - Merenda, Amedeo

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background: Most herpes simplex virus encephalitis (HSVE) patients become disabled despite antiviral therapy. Adjunctive corticosteroid therapy may improve outcomes. Methods: This was a systematic review of the literature addressing the use of corticosteroids in HSVE. Results: Data suggesting that steroids decrease the immunological response and enhance viral replication originated from non-neural microenvironments. Early steroid administration might be harmful because initial damage in HSVE is mediated by viral replication. Steroid treatment improves outcomes in animal models by inhibiting the subsequent inflammatory response. Clinical observations support a similar benefit in symptomatic HSVE patients. Cerebrospinal fluid inflammatory markers might guide appropriate timing in future clinical practice. Conclusions: Experimental and clinical observations suggest a benefit from adjunctive steroid therapy in HSVE. Nevertheless, current evidence is not yet sufficient to endorse this approach as a standard of practice.

AB - Background: Most herpes simplex virus encephalitis (HSVE) patients become disabled despite antiviral therapy. Adjunctive corticosteroid therapy may improve outcomes. Methods: This was a systematic review of the literature addressing the use of corticosteroids in HSVE. Results: Data suggesting that steroids decrease the immunological response and enhance viral replication originated from non-neural microenvironments. Early steroid administration might be harmful because initial damage in HSVE is mediated by viral replication. Steroid treatment improves outcomes in animal models by inhibiting the subsequent inflammatory response. Clinical observations support a similar benefit in symptomatic HSVE patients. Cerebrospinal fluid inflammatory markers might guide appropriate timing in future clinical practice. Conclusions: Experimental and clinical observations suggest a benefit from adjunctive steroid therapy in HSVE. Nevertheless, current evidence is not yet sufficient to endorse this approach as a standard of practice.

UR - http://www.scopus.com/inward/record.url?scp=84898614366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898614366&partnerID=8YFLogxK

U2 - 10.3851/IMP2683

DO - 10.3851/IMP2683

M3 - Article

C2 - 24009096

AN - SCOPUS:84898614366

VL - 19

SP - 133

EP - 139

JO - Antiviral Therapy

JF - Antiviral Therapy

SN - 1359-6535

IS - 2

ER -